TheraRadar

Pharma Intelligence, Simplified

← All Targets

Kappa opioid receptor

2 drugs
Market Leader
KORSUVA
VIFOR INTL
2
approved indications
2
Approved Drugs
2
Companies
3
Indications
0
Therapeutic Areas
Unlock Full Target Intelligence PRO
Competitive landscape by company (2 companies)
All 2 approved drugs
Therapeutic area breakdown
Full indication list (3 indications)
Patent cliff analysis
Clinical trials pipeline
Upgrade to Pro
Starting at $99/mo

Drugs by Company

VIFOR INTL 1 drug
AbbVie 1 drug

By Therapeutic Area

Other 2 drugs